Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC
Cited by 3
Related Papers
Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
|PubMed|2012|57
Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer
|Thoracic Cancer|2020|16
Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers
|Frontiers in Oncology|2021|13
Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover
|Cell Death Discovery|2024|4